Cite
Prognostic significance of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in breast cancer: a propensity score-matching study.
MLA
Jiang, Tongchao, et al. “Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Breast Cancer: A Propensity Score-Matching Study.” Cancer Cell International, vol. 24, no. 1, July 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12935-024-03419-w.
APA
Jiang, T., Sun, H., Xue, S., Xu, T., Xia, W., Wang, Y., Guo, L., & Lin, H. (2024). Prognostic significance of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in breast cancer: a propensity score-matching study. Cancer Cell International, 24(1), 1–16. https://doi.org/10.1186/s12935-024-03419-w
Chicago
Jiang, Tongchao, Haishuang Sun, Shuyu Xue, Tiankai Xu, Wen Xia, Ying Wang, Ling Guo, and Huanxin Lin. 2024. “Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Breast Cancer: A Propensity Score-Matching Study.” Cancer Cell International 24 (1): 1–16. doi:10.1186/s12935-024-03419-w.